Literature DB >> 11035416

The spectrum of ocular involvement in patients with systemic lupus erythematosus without ocular symptoms.

M P Soo1, S K Chow, C T Tan, N Nadior, S S Yeap, H B Hoh.   

Abstract

The aim of the study was to determine the spectrum of clinical ocular involvement in patients with inactive systemic lupus erythematosus (SLE) who have no ocular symptoms. Patients with a diagnosis of SLE based on the 1982 revised American College of Rheumatology criteria and with no ocular complaints were recruited from the SLE clinic. Clinical data regarding their systemic disease and disease activity were recorded and a full ophthalmic examination carried out. 52 patients of mixed ethnicity comprising of 75% Chinese, 19% Malays and 6% Indian patients were recruited. Of these, 51 (98%) were female with a mean age of 34+/-11 (range 16-74 y). 16 (31%) patients had dry eyes while corticosteroid induced glaucoma and cataract was detected in 1 (2%) and 7 (14%) patients, respectively. No patients were found to have sight-threatening ocular conditions such as cotton wool spots, vasculitis, optic neuropathy or uveitis. Patients with clinically inactive disease were found not to have sight-threatening ocular diseases that are known to be associated with SLE. Although they have no ocular complaints, nearly one-third of these patients have dry eyes. Ocular examination may be unnecessary when the disease is clinically inactive and in the absence of ocular symptoms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035416     DOI: 10.1177/096120330000900706

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  7 in total

1.  Risk factors for cataracts in systemic lupus erythematosus (SLE).

Authors:  Khaled Alderaan; Vuk Sekicki; Laurence S Magder; Michelle Petri
Journal:  Rheumatol Int       Date:  2014-09-26       Impact factor: 2.631

2.  Ocular manifestation of systemic lupus erythematosus.

Authors:  Rawhya R El-Shereef; Ahmad Shawkat Mohamed; Lamiaa Hamdy
Journal:  Rheumatol Int       Date:  2011-12-28       Impact factor: 2.631

3.  Are ocular complications of a high-dose glucocorticoid treatment appropriately monitored in patients with rheumatic diseases?

Authors:  Bobby Kwanghoon Han; Ralph Yachoui; Kayoung Yi
Journal:  Rheumatol Int       Date:  2012-08-22       Impact factor: 2.631

4.  Ophthalmic manifestations in patients with collagen vascular disorders: a hospital-based retrospective observational study.

Authors:  Surinder Kumar Sharma; Anju Lath Sharma; Vikram K Mahajan
Journal:  Int Ophthalmol       Date:  2021-04-08       Impact factor: 2.031

5.  Laser in situ keratomileusis in patients with collagen vascular disease: a review of the literature.

Authors:  Rachel G Simpson; Majid Moshirfar; Jason N Edmonds; Steven M Christiansen; Nicholas Behunin
Journal:  Clin Ophthalmol       Date:  2012-11-05

Review 6.  Dry Eye Disease: Consideration for Women's Health.

Authors:  Cynthia Matossian; Marguerite McDonald; Kendall E Donaldson; Kelly K Nichols; Sarah MacIver; Preeya K Gupta
Journal:  J Womens Health (Larchmt)       Date:  2019-01-29       Impact factor: 2.681

7.  Sjögren's syndrome: An underdiagnosed condition in mixed connective tissue disease.

Authors:  Fany Solange Usuba; Jaqueline Barros Lopes; Ricardo Fuller; Joyce Hisae Yamamoto; Milton Ruiz Alves; Sandra Gofinet Pasoto; Maria Teresa C Caleiro
Journal:  Clinics (Sao Paulo)       Date:  2014-03       Impact factor: 2.365

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.